News Briefs: Elevance’s Deal to Buy Louisiana Blues Hits Roadblocks

The $2.5 billion deal between Elevance Health, Inc. and Blue Cross and Blue Shield of Louisiana is facing some hiccups, per the New Orleans Times-Picayune. The Louisiana Blues affiliate must reissue ballots to 92,000 policyholders that will allow them to approve or reject the sale and invalidate proxy ballots that it’s already received. The insurer will also reschedule a meeting and official vote until after the state’s Dept. of Insurance has held a two-day hearing on the proposed sale. Louisiana Insurance Commissioner Jim Donelon and Attorney General and gubernatorial frontrunner Jeff Landry — both Republicans — have been critical of the deal, the Times-Picayune reported. The newspaper also said that attorneys in the state Dept. of Insurance “fully expect litigation” over the proposed transaction, which Elevance announced in January.

0 Comments
© 2024 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

healthcare-gov
July 12

Experts Challenge Specter of ‘Widespread’ ACA Enrollment Fraud

READ MORE
health-insurance
July 12

Study Outlines Limits on Medicaid-to-ACA-Plan Pipeline

READ MORE
doctor-holding-person’s-hand
July 12

Researchers Call for More Managed Medicaid Coverage for SUD Treatment

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today